Inclusion Criteria:
  1. Moderate/severe hypertensive left ventricular (LV) hypertrophy (LVMi ≥109 g/m² in women and ≥132 g/m² in men);
  2. New York Heart Association (NYHA) class II-III heart failure;
  3. Left ventricular ejection fraction > 50%;
  4. Increased LV filling pressures assessed at rest or at peak exercise by echocardiography
  5. Body mass index (BMI) > 30 kg/m²
  6. Signed and data informed consent
Exclusion Criteria:
  1. Age ≤ 18 years;
  2. Evidence of myocardial ischemia during stress echocardiography;
  3. Chronic atrial flutter or atrial fibrillation;
  4. Alternative cause of left ventricular hypertrophy and impaired diastolic function (hypertrophic/restictive cardiomyopathy, aortic stenosis, constrictive pericarditis and etc.);
  5. NYHA classification I or decompensated heart failure at screening;
  6. Systolic blood pressure < 110 mmHg or > 180 mmHg;
  7. Diastolic blood pressure < 40 mmHg or > 100 mmHg;
  8. Anemia (Hb < 100 g/l);
  9. Significant left sided structural valve disease;
 10. Secondary hypertension;
 11. Dyspnea due to non-cardiac causes such as pulmonary disease, anemia, severe obesity, primary valvular, or myocardial diseases;
 12. Myocardial infarction or myocardial revascularization within the last 3 months of screening;
 13. Stroke or TIA within the last 3 months of screening;
 14. Autoimmunic and oncological diseases;
 15. Impaired renal function, defined as eGFR < 30 ml/min/1.73 m²;
 16. Impaired liver function;
 17. Potassium concentration >5.2 mmol/L.